Abiopharma

Neutra Corp. was incorporated in Nevada on January 11, 2011 to market and participate in the nutraceutical space by bringing products derived from all natural and organic origins. Along with participating in the actual nutraceutical products, we plan to research and bring new technology to the nutraceutical space. Nutraceutical natural medicine is an alternative system that focuses on natural remedies and the bodys vital ability to heal and maintain itself. One of the nutraceutical sub-markets is the new thriving hemp-based cannabis market, in which we intend to participate. We have a full hemp-based manufacturing facility in Katy, TX where we manufacture all of our products and sell them under our unique brand, VIVIS. As the global cannabis market grows exponentially, it is constantly in need of better technologies and products to be more efficient in how it grows, what it grows and how it consumes cannabis and its related products. In 2022, Neutra started to venture into corporate development for clinical research which was a natural bridge in researching hemp-based cannabis products. Neutra intends to further explore the clinical research market in possible mergers or acquisitions in the space.

Additional info from OTC:
Neutra Corp. was incorporated in Nevada on January 11, 2011 to market and participate in the nutraceutical space by bringing products derived from all natural and organic origins. Along with participating in the actual nutraceutical products, we plan to research and bring new technology to the nutraceutical space. Nutraceutical natural medicine is an alternative system that focuses on natural remedies and the bodys vital ability to heal and maintain itself. One of the nutraceutical sub-markets is the new thriving hemp-based cannabis market, in which we intend to participate. We have a full hemp-based manufacturing facility in Katy, TX where we manufacture all of our products and sell them under our unique brand, VIVIS. As the global cannabis market grows exponentially, it is constantly in need of better technologies and products to be more efficient in how it grows, what it grows and how it consumes cannabis and its related products. In 2022, Neutra started to venture into corporate development for clinical research which was a natural bridge in researching hemp-based cannabis products. Neutra intends to further explore the clinical research market in possible mergers or acquisitions in the space.